nevena damjanov, md, discusses identifying subgroups of patients for targeted therapies in hcc
Published 7 years ago • 62 plays • Length 0:47
Download video MP4
Download video MP3
Similar videos
-
1:13
nevena damjanov, md, comments on identifying subgroups of patients for targeted therapies in hcc
-
1:47
nevena damjanov, md, discusses how new agents for advanced hcc will be integrated into the treatment
-
1:39
ghassan abou-alfa, md, on identifying subgroups of patients for targeted therapies in hcc
-
0:34
nevena damjanov, md, shares thoughts on the role of systemic therapy in hcc
-
0:55
nevena damjanov, md, discusses new agents being studied for treatment of advanced hcc
-
0:46
nevena damjanov, md, outlines the role of tace with systemic therapy in hcc patients
-
1:16
nevena damjanov, md, discusses current treatment options and sequencing tkis in hcc
-
0:49
nevena damjanov, md, regarding the impact of the redos study in hcc
-
48:39
dr. mimi canto: pancreatic cancer screening and surveillance in high-risk individuals
-
7:22
pd-1 inhibition in lung cancer
-
1:14:21
gastric carcinoma- adjuvant/ neoadjuvant target volume delineation
-
0:54
nevena damjanov, md, regarding sequencing tkis in hepatocellular carcinoma (hcc)
-
0:32
nevena damjanov, md, shares personal opinion of treatment of patient with a high expression of afp
-
1:01
nevena damjanov, md, explains how checkpoint inhibitors will be incorporated into the treatment
-
0:39
nevena damjanov, md, explains the outcomes of the resorce trial as presented here at asco gi 2017
-
0:43
nevena damjanov, md, on combining cabozantinib with checkpoint inhibitors in advanced hcc patients
-
0:35
nevena damjanov, md, elaborates on stereotactic body radiation therapy in early stage hcc
-
0:35
nevena damjanov, md, on the use of pembrolizumab in hcc patients previously treated with sorafenib
-
0:49
nevena damjanov, md, considers the shortcomings of recist in measuring efficacy in hcc patients
-
0:44
nevena damianov, md discusses the toxicity concerns and how to manage them for sorafenib in hcc
-
1:14
nevena damjanov, md, on the phase 3 checkpoint 459 trial studying nivolumab in hcc
-
0:37
nevena damjanov, md, on whether regorafenib will be integrated into clinical practice
Clip.africa.com - Privacy-policy